A $500,000 loan from the state of Ohio will help AxioMed Spine manufacture and launch the company’s second product, an artificial cervical spine disc.

AxioMed Spine Corp. has raised $14.5 million in Series D funding to help the Garfield Heights, Ohio company finish enrolling patients for a pivotal U.S. clinical study of its lumbar disc replacement, as well as earn CE Mark approval for its cervical disc and start sales in Europe.The developer of next-generation spinal disc replacements said [...]

Updated 4:36 p.m.Cleveland Clinic Innovations — the corporate venturing arm of the nation’s top heart hospital — is entering its second decade with a first-of-its-kind venture ranking, a brand-new incubator building and a growing portfolio of spin-out companies.AdvertisementPerhaps most impressive, those companies — 33 in all — have attracted more than $340 million in follow-on [...]

MedCity News President Chris Seper appeared on air of content partner WKYC-TV, discussing three Cleveland-area medical device companies: AxioMed Spine, CerviLenz and Neuros Medical.

AxioMed Spine Corp. has completed the first part of its third round of financing, raising $6.4 million from “leading venture capital firms” on its way to a $18.5 million goal.

AxioMed Spine Corp. said Tuesday it has received Europe’s CE Marking — much like Food and Drug Administration market clearance in the United States — to introduce its disc replacement for the lower spine to the 27 countries that belong to the European Union. It’s the first market clearance for Freedom — one of a small group of next-generation spinal disc replacements designed to function more like the natural spine.